SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Challenges in the Implementation of the NeoOBS Study, a Global Pragmatic Observational Cohort Study, to Investigate the Aetiology and Management of Neonatal Sepsis in the Hospital Setting.

Riddell, A; Cook, A; Khavessian, N; Ellis, S; Bilardi, D; Correia, E; Kostyanev, T; Nardone, A; Russell, N; Vilken, T; et al. Riddell, A; Cook, A; Khavessian, N; Ellis, S; Bilardi, D; Correia, E; Kostyanev, T; Nardone, A; Russell, N; Vilken, T; Stohr, W; Adhisivam, B; Moraes, IRAD; Ahmed, NU; Bekker, A; Berezin, EN; Boonkasidecha, S; Carvalheiro, CG; Chauhan, P; Chiurchiù, S; Chorafa, E; Dramowski, A; Ds, M; Feng, J; Jia, S; Kong, Y; Kyohere, M; Kontou, A; Lochindarat, S; De Luca, M; Mphaphuli, A; Mussi-Pinhata, MM; Murunga, S; Nakwa, FL; Nangia, S; Nassolo, E; Hoang, NTB; Obiero, CW; Olson, L; Ping, W; Plakkal, N; Prasad, P; Preedisripipat, K; Rahman, SW; Seef, T; Sukrakanchana, P-O; Thomas, R; Yu, Z; Zhang, Q; Walker, AS; Bielicki, J; Heath, PT; Sharland, M; Munera-Huertas, T (2023) Challenges in the Implementation of the NeoOBS Study, a Global Pragmatic Observational Cohort Study, to Investigate the Aetiology and Management of Neonatal Sepsis in the Hospital Setting. Antibiotics (Basel), 12 (5). p. 923. ISSN 2079-6382 https://doi.org/10.3390/antibiotics12050923
SGUL Authors: Sharland, Michael Roy

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Neonatal sepsis is a significant cause of mortality and morbidity in low- and middle-income countries. To deliver high-quality data studies and inform future trials, it is crucial to understand the challenges encountered when managing global multi-centre research studies and to identify solutions that can feasibly be implemented in these settings. This paper provides an overview of the complexities faced by diverse research teams in different countries and regions, together with actions implemented to achieve pragmatic study management of a large multi-centre observational study of neonatal sepsis. We discuss specific considerations for enrolling sites with different approval processes and varied research experience, structures, and training. Implementing a flexible recruitment strategy and providing ongoing training were necessary to overcome these challenges. We emphasize the attention that must be given to designing the database and monitoring plans. Extensive data collection tools, complex databases, tight timelines, and stringent monitoring arrangements can be problematic and might put the study at risk. Finally, we discuss the complexities added when collecting and shipping isolates and the importance of having a robust central management team and interdisciplinary collaborators able to adapt easily and make swift decisions to deliver the study on time and to target. With pragmatic approaches, appropriate training, and good communication, these challenges can be overcome to deliver high-quality data from a complex study in challenging settings through a collaborative research network.

Item Type: Article
Additional Information: Copyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Keywords: LMIC, antibiotic treatment, antimicrobial resistance, clinical trials, empiric antibiotics, global collaboration, neonatal sepsis
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Antibiotics (Basel)
ISSN: 2079-6382
Language: eng
Dates:
DateEvent
17 May 2023Published
26 April 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 37237826
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115492
Publisher's version: https://doi.org/10.3390/antibiotics12050923

Actions (login required)

Edit Item Edit Item